Warning over return of 19th century disease after 4,332 deaths
There have been fatal outbreaks in 31 countries, according to the World Health Organisation
The bacterium Vibrio cholerae
The World Health Organisation (WHO) has issued an alert over the rising number of cases of cholera after thousands of deaths. Cholera is an acute infectious disease caused by the bacterium Vibrio cholerae.
It primarily spreads through contaminated water or food and causes severe watery diarrhoea, which can lead to dangerous dehydration and death if untreated. It thrives in areas with poor sanitation and unsafe drinking water. In the 1800s, cholera was one of the most feared diseases worldwide, causing several global pandemics with major outbreaks in Europe, North America, and Asia.
The global cholera situation continues to deteriorate, driven by conflict and poverty.
This year, more than 390,000 cholera cases and 4,332 deaths have been reported across 31 countries. WHO says the figures are underestimates, but they 'reflect a collective failure'.
A WHO spokesman said: "Cholera is preventable and easily treatable, yet it continues to claim lives. We are especially concerned about cholera in Sudan, Chad; in the Democratic Republic of the Congo; South Sudan; and Yemen. In all these countries, conflict is fuelling cholera.
"One year after the start of the outbreak in Sudan, cholera has reached every state. This year alone, there have been nearly 50 000 (48 768) cases and over 1000 (1094) deaths reported, with a high fatality rate of 2.2%, exceeding the 1% threshold which indicates adequate treatment."
Article continues below
While cases have plateaued or decreased in some areas, including Khartoum, they are rising in the Darfur region, and affecting neighboring Chad.
The rainy season has started and is expected to worsen, WHO has stepped up its response in the Darfur region and neighbouring Chad, anticipating worsening sanitation and flooded roads which will affect access both for aid workers and supplies.
A spokesman said: "Working alongside partners, we've established national and local task forces, deployed rapid response teams for surveillance, and stockpiled essential cholera supplies in the region. Thanks to joint efforts, 17 cholera treatment centres with a total capacity of 670 beds are operational in Darfur. We have strengthened surveillance, trained health workers on clinical care and infection control, funded water quality testing and are coordinating cross-border public health efforts with Chad.
"But violence and bureaucracy are blocking access. Large parts of Darfur and Kordofan remain unreachable.
"Since December, oral cholera vaccine production has hit record levels - 6 million doses monthly, the highest since 2013 - thanks to new formulations. But record production has been outpaced by record demand.
"Since January, the International Coordinating Group on Vaccine Provision (ICG) has received 38 requests from 12 countries—triple the number compared to the same period last year. Already this year, over 40 million doses have been allocated, compared to 35 million doses allocated in all of 2024. "
In the Democratic Republic of the Congo, over 44 521 cases and 1238 deaths have been reported this year, mostly in the conflict-affected east. In South Sudan, there have been nearly 70,310 cases and over 1,158 deaths.
In Yemen, there have been over 60,794 cases and 164 deaths.
The spokesman said: "These figures have two things in common: one, they are too high, too many people have been affected, and two, they are driven by conflict. Conflict is forcing people to flee, often into crowded camps where water, sanitation and hygiene facilities are stretched. And the overall response is crippled with overextended human resources, gaps in data and serious funding shortfalls."
Article continues below
WHO is urging governments and the international community to mobilise urgent funding, support the rapid deployment of vaccines and supplies, and safe access for aid workers and invest in long-term prevention through water and sanitation, and stronger surveillance systems.
The spokesman said: "No one should die because they don't have access to safe water."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wales Online
18 hours ago
- Wales Online
Warning over return of 19th century disease after 4,332 deaths
Warning over return of 19th century disease after 4,332 deaths There have been fatal outbreaks in 31 countries, according to the World Health Organisation The bacterium Vibrio cholerae The World Health Organisation (WHO) has issued an alert over the rising number of cases of cholera after thousands of deaths. Cholera is an acute infectious disease caused by the bacterium Vibrio cholerae. It primarily spreads through contaminated water or food and causes severe watery diarrhoea, which can lead to dangerous dehydration and death if untreated. It thrives in areas with poor sanitation and unsafe drinking water. In the 1800s, cholera was one of the most feared diseases worldwide, causing several global pandemics with major outbreaks in Europe, North America, and Asia. The global cholera situation continues to deteriorate, driven by conflict and poverty. This year, more than 390,000 cholera cases and 4,332 deaths have been reported across 31 countries. WHO says the figures are underestimates, but they 'reflect a collective failure'. A WHO spokesman said: "Cholera is preventable and easily treatable, yet it continues to claim lives. We are especially concerned about cholera in Sudan, Chad; in the Democratic Republic of the Congo; South Sudan; and Yemen. In all these countries, conflict is fuelling cholera. "One year after the start of the outbreak in Sudan, cholera has reached every state. This year alone, there have been nearly 50 000 (48 768) cases and over 1000 (1094) deaths reported, with a high fatality rate of 2.2%, exceeding the 1% threshold which indicates adequate treatment." Article continues below While cases have plateaued or decreased in some areas, including Khartoum, they are rising in the Darfur region, and affecting neighboring Chad. The rainy season has started and is expected to worsen, WHO has stepped up its response in the Darfur region and neighbouring Chad, anticipating worsening sanitation and flooded roads which will affect access both for aid workers and supplies. A spokesman said: "Working alongside partners, we've established national and local task forces, deployed rapid response teams for surveillance, and stockpiled essential cholera supplies in the region. Thanks to joint efforts, 17 cholera treatment centres with a total capacity of 670 beds are operational in Darfur. We have strengthened surveillance, trained health workers on clinical care and infection control, funded water quality testing and are coordinating cross-border public health efforts with Chad. "But violence and bureaucracy are blocking access. Large parts of Darfur and Kordofan remain unreachable. "Since December, oral cholera vaccine production has hit record levels - 6 million doses monthly, the highest since 2013 - thanks to new formulations. But record production has been outpaced by record demand. "Since January, the International Coordinating Group on Vaccine Provision (ICG) has received 38 requests from 12 countries—triple the number compared to the same period last year. Already this year, over 40 million doses have been allocated, compared to 35 million doses allocated in all of 2024. " In the Democratic Republic of the Congo, over 44 521 cases and 1238 deaths have been reported this year, mostly in the conflict-affected east. In South Sudan, there have been nearly 70,310 cases and over 1,158 deaths. In Yemen, there have been over 60,794 cases and 164 deaths. The spokesman said: "These figures have two things in common: one, they are too high, too many people have been affected, and two, they are driven by conflict. Conflict is forcing people to flee, often into crowded camps where water, sanitation and hygiene facilities are stretched. And the overall response is crippled with overextended human resources, gaps in data and serious funding shortfalls." Article continues below WHO is urging governments and the international community to mobilise urgent funding, support the rapid deployment of vaccines and supplies, and safe access for aid workers and invest in long-term prevention through water and sanitation, and stronger surveillance systems. The spokesman said: "No one should die because they don't have access to safe water."
Daily Mirror
2 days ago
- Daily Mirror
Deadly Oropouche virus could have 'severe consequences' for pregnant women
The UK Health Security Agency (UKHSA) confirmed three instances of oropouche virus linked to trips to Brazil were found in the UK amid fears the disease "should not be underestimated" An expert has issued a stark warning that the initial cases of the lethal Oropouche virus detected in the UK could pose "severe consequences" for expectant mums. The UK Health Security Agency (UKHSA) confirmed three instances of oropouche virus linked to trips to Brazil. The illness, which resembles the flu, can cause symptoms such as fever, headaches, joint pain, muscle pain, chills, nausea and vomiting. Officials have urged anyone who becomes unwell with these symptoms after travelling to affected areas, including parts of Central and South America and the Caribbean, to seek urgent medical advice. According to the World Health Organisation (WHO), before late 2023, the oropouche virus was mostly reported near the Amazon rainforest area. However, in 2024, locally transmitted cases of the disease were reported in Brazil, Bolivia, Colombia, Cuba, Guyana, Peru and the Dominican Republic. Dr Enny Paixao, an associate professor at the London School of Hygiene and Tropical Medicine, warns the virus should "not be underestimated", particularly for expectant mothers. It comes after the Oropouche virus was found in the UK for the first time after sweeping through Europe. Last year, a woman heartbreakingly lost her baby in Pernambuco, Brazil, after contracting the Oropouche virus. Additionally, a second incident occurred in Acre where a newborn with birth defects caused by mother-to-child transmission sadly passed away after 47 days. The World Health Organisation reports three further potential instances of mother-to-child transmission are under investigation in Pernambuco. The specialist warns these discoveries should "underscore the urgent need for further investigation, which should be considered a public health priority." She told The Mirror: "The potential public health implications should not be underestimated. Although OROV infection is typically mild and self-limiting, previous outbreaks reported by PAHO and the Brazilian Ministry of Health have included fatalities. In Brazil, several confirmed or suspected cases of vertical transmission have also been documented, with severe consequences for the fetus. "Since last year, samples from cases of microcephaly of unknown etiology have been tested for Oropouche virus, and some have tested positive. Last year, a documented case of vertical transmission of Oropouche virus was reported in the state of Pernambuco, resulting in fetal death. "Subsequently, a second case was reported in Acre, in which a neonate born with congenital anomalies attributed to vertical transmission, including microcephaly, ventriculomegaly, agenesis of the corpus callosum, and joint malformations, died after 47 days. These are published in Lancet Infectious Disease. "These findings underscore the urgent need for further investigation, which should be considered a public health priority. "Pregnant women should be counselled on preventive measures, particularly the use of mosquito bite protection, as this not only reduces the risk of Oropouche virus infection but also protects against other mosquito borne diseases, including Zika, dengue, and chikungunya."
Daily Mail
3 days ago
- Daily Mail
Scientists discover how terrifying cancer-causing parasitic worm can penetrate your body... without you feeling a thing
If a worm was trying to burrow into your skin, you'd be forgiven for thinking you'd feel it gnawing at your flesh—but scientists have identified how one wriggling parasite does so without you noticing. Schistosoma mansoni—also known as a blood fluke—is a 17mm-long flatworm which causes a chronic disease called intestinal schistosomiasis, which kills hundreds of thousands of people every year. It is the most prevalent parasite in humans—in 2021, the World Health Organisation estimated that there were 251.4 million people living with schistosomiasis across the globe—with the disease most widespread in Africa, parts of South America, the Caribbean, and the Middle East. Infection occurs during contact with infested water through activities like swimming, washing clothes, and fishing, when larvae—hosted in snails who have eaten eggs contained in infected human faeces—penetrate the skin. Once inside, it releases thousands of eggs that can spread through the body infecting vital organs. A new mouse study by researchers at the Tulane School of Medicine explored why blood flukes don't cause pain or itching when it penetrates the skin. Their findings show that the worm—referred to in scientific circles as S. mansoni— causes a reduction in the activity of TRPV1+, a protein that sends signals the brain interprets as heat, pain, or itching. Surprisingly, this also means that the worm often evades detection by the immune system, unlike other bacteria or parasites that typically cause pain, itching, or rashes. However, while the discovery, published in The Journal of Immunology, is undeniably skin-crawling, researchers hope that it could have some medical benefit. Study lead Dr. De'Broski R. Herbert, Professor of Immunology at Tulane School of Medicine, said that the worms could lead to new advances in pain medication, anti-inflammatories, and even preventative treatment against intestinal schistosomiasis He said: 'If we identify and isolate the molecules used by [parasitic worms] to block TRPV1+ activation, it may present a novel alternative to current opioid-based treatments for reducing pain. 'The molecules that block TRPV1+ could also be developed into therapeutics that reduce disease severity for individuals suffering from painful inflammatory conditions.' In May, it was reported that the number of British travellers who have brought the parasite home with them had reached a record high. Also called snail fever or bilharzia schistosomiasis, the infection can cause infertility, blindness, severe organ damage, and even bladder cancer if left untreated. Scientists speaking at Wellcome Trust in London in May said while the disease was once confined to sub-Saharan Africa, it is now spreading in parts of southern Europe. Outbreaks have been reported in the freshwater lakes and rivers of European holiday favourites like Spain, Portugal and parts of France. Official UK Government data shows an increasing number of British travellers are also being infected. The UK Health Security Agency recorded 123 cases in Britain in 2022, more than double the number tallied in the previous year and nearly triple the number recorded before the Covid pandemic. Bonnie Webster, principal researcher at the Schistosome Snail Resource at the Natural History Museum, said the worm is believed to have reached Europe from African travellers. 'It was people travelling from Africa, particularly Senegal, who imported the parasites,' she said according to The Telegraph. What is schistosomiasis? Schistosomiasis is an infection caused by a burrowing parasitic worm that lives in freshwater in tropical regions of Africa, South America, the Caribbean, the Middle East and Asia. It affects around 600 million people worldwide and kills 300,000 a year. Although the infection usually does not cause symptoms at first, it can gradually damage organs such as the bladder, kidneys and liver. Within a few weeks of infection, people may suffer fever, rashes, diarrhoea and abdominal pain. In the long term, schistosomiasis can cause organs to become permanently damaged, leading to seizures if the brain is affected, coughing up blood if the lungs are damaged and anaemia if the digestive system was targeted. 'Once one snail is infected, they infect a whole population of snails which then infect a whole population of humans.' Experts believe importation by tourists, combined with climate change making European waters warmer and more hospitable for the worms, are behind a rise in infections on the continent. However, as snail fever can be mistaken for host of other conditions, and sometimes cause no symptoms, many more people may be infected than official figures suggest. Infected humans can contaminate freshwater sources with the worm by shedding eggs in their urine and faeces. From there the worm infects a freshwater snail, where it grows to a size that enables it to infect a human. Infections can initially manifest as an itchy bumpy rash, colloquially known as 'swimmers itch'. As the illness develops, symptoms include fever, more rashes, a cough, diarrhoea, muscle and joint pain, stomach ache and a general sense of being unwell. These symptoms aren't caused by the worm itself but rather the body's reaction to it releasing thousands upon thousands of eggs. Experts say snail fever is often misdiagnosed at this stage as the result of some other infection. While the disease generally clears up on its own, patients are still at risk of long term health complications like organ damage as the parasite remains in their body. In rare cases, the eggs can reach the brain and spinal cord where it can cause a host of serious health problems. The NHS advises people who experience signs of infection, and who have been in an area where the worms are found, to contact their GP for advice. Treatment for snail fever involves taking a drug called praziquantel which kills the worms. People can reduce their risk of snail fever by avoiding swimming or paddling in fresh water as the worms cannot survive in the sea or in chlorinated swimming pools.
